© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0124T involves a conjunctival incision with posterior extrascleral placement of a pharmacological agent. This technique is primarily utilized in the treatment of age-related macular degeneration (AMD), a condition characterized by the deterioration of the central portion of the retina, leading to vision loss. The pharmacological agent typically used in this procedure is a depot suspension of an angiostatic cortisene, which plays a crucial role in inhibiting ocular neovascularization—a common complication associated with AMD. By preventing the proteolysis necessary for the migration of vascular endothelial cells, the angiostatic cortisene helps to mitigate the progression of abnormal blood vessel growth in the eye. The procedure begins with a careful incision in the conjunctiva, allowing access to the underlying Tenons capsule and the sclera. The use of a blunt-tipped, curved cannula facilitates the precise placement of the pharmacological agent in the extrascleral space, ensuring that it is delivered effectively near the macula. This method is designed to optimize the therapeutic effects of the medication while minimizing potential complications associated with direct scleral incision.
© Copyright 2025 Coding Ahead. All rights reserved.
The conjunctival incision with posterior extrascleral placement of a pharmacological agent is indicated for the treatment of specific ocular conditions, particularly:
The procedure involves several critical steps to ensure the effective placement of the pharmacological agent:
Post-procedure care involves monitoring the patient for any immediate complications and ensuring proper healing of the conjunctival incision. Patients may be advised to avoid strenuous activities and to follow up with their healthcare provider for any necessary evaluations. The application of a semi-pressure patch helps to stabilize the area and reduce discomfort. Patients should be informed about potential side effects and the importance of reporting any unusual symptoms, such as increased pain or vision changes, to their physician promptly.
| Short Descr | CONJUNCTIVAL DRUG PLACEMENT | Medium Descr | CONJUNCTVL INC W/POST XTRSCLERA PLCMT PHARM AGNT | Long Descr | Conjunctival incision with posterior extrascleral placement of pharmacological agent (does not include supply of medication) | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Multiple Reduction Applies | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 19 - Other therapeutic procedures on eyelids, conjunctiva, cornea |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2014-01-01 | Deleted | Deleted |
| 2009-01-01 | Changed | Code description changed. |
| 2008-07-01 | Changed | Code description changed |
| 2006-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.